FDA Approvals - Genzyme Announces FDA Approval of Framingham Manufacturing PlantGenzyme, a Sanofi
Genzyme Announces FDA Approval of Framingham Manufacturing Plant
Genzyme, a Sanofi company , announced today that the Food and Drug Administration has approved its manufacturing plant in Framingham, Mass., for the production of Fabrazyme .
FDA OKs Genzyme s Framingham plant
Less than a week after Genzyme's Framingham plant landed approval from the European Medicines Agency to manufacture Fabrazyme, the U.S. Food and Drug Administration has also given the OK to produce the treatment for Fabry disease.
China Kanghui Holdings Receives FDA Approvals for Hip and Knee Systems
CHANGZHOU, China , Jan. 6, 2012 /PRNewswire-Asia/ -- China Kanghui Holdings (NYSE: KH - News) ("Kanghui" or the "Company"), a leading domestic developer, manufacturer and marketer of orthopedic ...